Severe anemia early in life as a risk factor for sickle-cell kidney disease

Blood

Volumn 129, Issue 3, 2017, Pages 385-387

  Aban, Inmaculada ^a   Baddam, Sujatha ^a   Hilliard, Lee M ^a   Howard, Thomas H ^a   Feig, Daniel I ^a   Lebensburger, Jeffrey D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; HEMOGLOBIN; HYDROXYUREA;

ADOLESCENT; ALBUMIN URINE LEVEL; BLOOD TRANSFUSION; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSTITUTIONAL REVIEW; KIDNEY DISEASE; LETTER; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MICROALBUMINURIA; PRIORITY JOURNAL; RISK FACTOR; SICKLE CELL ANEMIA; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; THROMBOCYTE; THROMBOCYTE COUNT; URINE LEVEL; BLOOD; CHILD; COMPLICATION;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; FEMALE; HUMANS; KIDNEY DISEASES; MALE; RISK FACTORS;

EID: 85028190226     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-09-738104     Document Type: Letter

References (24)

1. Nielsen L, Canouï-Poitrine F, Jais JP, et al. Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non-sickle dialysis patients. Br J Haematol. 2016;174(1):148-152.
2. Powars DR, Elliott-Mills DD, Chan L, et al. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med. 1991;115(8):614-620.
3. Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825-830.
4. Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware RE. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr Nephrol. 2011;26(8):1285-1290.
5. Lebensburger J, Johnson SM, Askenazi DJ, Rozario NL, Howard TH, Hilliard LM. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia. Am J Hematol. 2011;86(5):430-432.
6. McPherson Yee M, Jabbar SF, Osunkwo I, et al. Chronic kidney disease and albuminuria in children with sickle cell disease. Clin J Am Soc Nephrol. 2011; 6(11):2628-2633.
7. Becton LJ, Kalpatthi RV, Rackoff E, et al. Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol. 2010; 25(8):1505-1511.
8. Gurkan S, Scarponi KJ, Hotchkiss H, Savage B, Drachtman R. Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatr Nephrol. 2010;25(10):2123-2127.
9. Guasch A, Navarrete J, Nass K, Zayas CF. Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol. 2006;17(8):2228-2235.
10. Haymann JP, Stankovic K, Levy P, et al. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin J Am Soc Nephrol. 2010;5(5):756-761.
11. McClellan AC, Luthi JC, Lynch JR, et al. High one year mortality in adults with sickle cell disease and end-stage renal disease. Br J Haematol. 2012;159(3): 360-367.
12. Ojo AO, Govaerts TC, Schmouder RL, et al. Renal transplantation in end-stage sickle cell nephropathy. Transplantation. 1999;67(2):291-295.
13. Huang E, Parke C, Mehrnia A, et al. Improved survival among sickle cell kidney transplant recipients in the recent era. Nephrol Dial Transplant. 2013;28(4): 1039-1046.
14. Lebensburger JD, Miller ST, Howard TH, et al; BABY HUG Investigators. Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study. Pediatr Blood Cancer. 2012; 59(4):675-678.
15. Wolf RB, Saville BR, Roberts DO, et al. Factors associated with growth and blood pressure patterns in children with sickle cell anemia: Silent Cerebral Infarct Multi-Center Clinical Trial cohort. Am J Hematol. 2015;90(1):2-7.
16. Juncos JP, Grande JP, Croatt AJ, et al. Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease. Am J Physiol Renal Physiol. 2010;298(4):F892-F899.
17. Nath KA, Grande JP, Croatt AJ, et al. Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol. 2005;166(4): 963-972.
18. Shankar A, Sun L, Klein BE, et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int. 2011;80(11):1231-1238.
19. Mielniczuk LM, Pfeffer MA, Lewis EF, et al. Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. Clin J Am Soc Nephrol. 2009;4(11):1811-1817.
20. Hsu YH, Li HH, Sung JM, Chen WT, Hou YC, Chang MS. Interleukin-19 mediates tissue damage in murine ischemic acute kidney injury. PLoS One. 2013;8(2):e56028.
21. Wang WC, Ware RE, Miller ST, et al; BABY HUG investigators. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011; 377(9778):1663-1672.
22. Bartolucci P, Habibi A, Stehlé T, et al. Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease. J Am Soc Nephrol. 2016;27(6): 1847-1853.
23. Wagner MG, Smith FG Jr, Tinglof BO Jr, Cornberg E. Epidemiology of proteinuria. A study of 4,807 schoolchildren. J Pediatr. 1968;73(6):825-832.
24. Vehaskari VM, Rapola J. Isolated proteinuria: analysis of a school-age population. J Pediatr. 1982;101(5):661-668.